Earlier today, Co-Diagnostics released financial results from the third quarter ended 09/30/2025. In addition to diagnostic ...
Co-Diagnostics, Inc. ("Co-Diagnostics," "Co-Dx," or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced ...
Ultrafiltration membranes used in pharmaceutical manufacturing and other industrial processes have long relied on separating ...
A research team led by the A*STAR Genome Institute of Singapore (A*STAR GIS) have developed a method to accurately and ...
Promising results from a small clinical trial highlight a growing interest in designing gene-editing treatments for common ...
Recommendations for Interventional Trials (SPIRIT) 2025 guidelines published in The Lancet and commend the efforts to enhance transparency and rigour in clinical trial protocols.1,2 Accurate and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback